{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-021645","form_type":"8-K","ticker":"FLGT","cik":"0001674930","company_name":"Fulgent Genetics, Inc.","filed_at":"2024-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.070104+00:00","generated_at":"2026-06-05T09:03:30.874637+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Fulgent Genetics reports Q4 GAAP loss $128.1M; core revenue grows 21% YoY","bullets":["Full year total revenue $289.2M; core revenue (ex-COVID) grew 44% to $262.1M.","Q4 total revenue $70.5M; core revenue grew 21% to $66.5M.","Q4 GAAP net loss $128.1M ($4.30 per share); non-GAAP income $8.3M ($0.28 per share).","Full year GAAP net loss $167.8M ($5.63 per share); non-GAAP loss $12.3M ($0.41 per share).","Cash and investments $847.7M as of Dec 31, 2023; repurchased 953k shares for $25.1M in FY 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-021645","json":"https://secwatch.observer/filing/0000950170-24-021645.json","markdown":"https://secwatch.observer/filing/0000950170-24-021645.md","text":"https://secwatch.observer/filing/0000950170-24-021645.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674930/000095017024021645/0000950170-24-021645-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674930/000095017024021645/flgt-20240228.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T09:03:30.874637+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4ffa10f0d9d3fef6ce34a43ec3b07b882b16a0e8","claim":"Fulgent Genetics, Inc. reported fiscal quarter and year ended December 31, 2023 results: revenue Total Revenue of $289.2 million, net income GAAP loss of $167.8 million, EPS $5.63 per share.","evidence_excerpt":"Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results • Full Year 2023 Total Revenue of $289.2 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1674930/000095017024021645/0000950170-24-021645-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal quarter and year ended December 31, 2023"},{"label":"Revenue","value":"Total Revenue of $289.2 million"},{"label":"Net income","value":"GAAP loss of $167.8 million"},{"label":"EPS","value":"$5.63 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}